Companies Investors People

Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

Contact
Request a Demo
Request Data Updates
Add a Company

Research

Companies
Investors
People

aVenture

Download App
Pricing

Resources

Documentation
Use Cases
CLI
MCP
Feature Requests
Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading

Joshua Kazam - aVenture Research

Joshua Kazam

AddedMar 31, 2024

UpdatedOct 12, 2026

Joshua Kazam

Joshua Kazam

Co-Founder, Two River

Joshua Kazam's Career

Riverbank Capital Securities

Investment Firm

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview

aVenture product preview

aVenture product preview

Joshua Kazam's Investments

1 investments since 2018

1 operating

Investments view

Group by

2018

1

Andie
Seed · March 2018$2M
Seed · March 2018

New York City, NY, US

Board Member· Board

Vida Ventures

Investment FirmBoston, MA, US

Board Member· Board

Bellco Capital

Investment FirmLos Angeles, CA, US

Board Member· Board

Two River

Investment FirmNew York City, NY, US

Co-Founder

Kronos Bio

Public$278MSan Mateo, CA, US

Co-Founder

Allogene Therapeutics

Public$781.8MSouth San Francisco, CA, US

Board Member· Board

IconOVir Bio

Series A$77MSan Diego, CA, US

Board Member· Board

Kirax

Public$540.8kBonita Springs, FL, US

Board Member· Board

Hubble Contacts

Series B$78.7MNew York City, NY, US

Board Member· Board

People Similar to Joshua Kazam

John DeYoungBoard Member · Allogene Therapeutics

David BondermanCo-Founder · TPG Capital Asia

Franz HumerBoard Member · Kite Pharma

Todd SisitskyBoard Member · Allogene Therapeutics

Leadership at Riverbank Capital Securities

Peter Morgan KashBoard Member

Similar to Riverbank Capital Securities

SI SecuritiesNew York City, NY, USest. 2013SI SecuritiesNew York City, NY, US · est. 2013

SI Securities, LLC: Expert financial brokerage firm specializing in trading stocks, bonds, and mutual funds.

Investment Firm30

Flying Cloud SecuritiesSan Francisco, CA, USest. 2013Flying Cloud SecuritiesSan Francisco, CA, US · est. 2013

Flying Cloud Securities LLC: Specialized financial brokerage for stocks, bonds, and mutual funds.

Investment Firm2

Bank of America SecuritiesNew York City, NY, USBank of America SecuritiesNew York City, NY, US

Bank of America Securities: Investment banking subsidiary offering trading, brokerage services.

Investment Firm10k

Javcap SecuritiesNew York City, NY, USest. 2006Javcap SecuritiesNew York City, NY, US · est. 2006

NYC-based Alternative Investment Services, LLC specializes in financial brokerage and trading securities.

Investment Firm15

Leadership at Vida Ventures

Arjun GoyalCo-Founder

Stefan VitorovicCo-Founder

Raul JainBoard Member

Similar to Vida Ventures

Third Rock VenturesBoston, MA, USest. 2007Third Rock VenturesBoston, MA, US · est. 2007

Third Rock Ventures: A venture capital firm investing in life sciences and biotech in MA and CA.

Investment Firm148

Bioventures InvestorsWellesley, MA, USest. 1998Bioventures InvestorsWellesley, MA, US · est. 1998

BioVentures Investors, LLC: A US-based venture capital firm specializing in life sciences and healthcare sectors.

Investment Firm12

LifeSci Venture PartnersNew York City, NY, USest. 2017LifeSci Venture PartnersNew York City, NY, US · est. 2017

LifeSci Venture Partners, formed in 2017, is an early-stage investment firm in life sciences and healthcare.

Investment Firm5

Versant VenturesSan Francisco, CA, USest. 1999Versant VenturesSan Francisco, CA, US · est. 1999

Versant Ventures: A leading healthcare investment firm, focusing on novel therapeutic biotechnology.

Investment Firm68

Leadership at Bellco Capital

Rebecka BelldegrunCEO

Similar to Bellco Capital

Belle CapitalDouglas, AZ, USest. 2013Belle CapitalDouglas, AZ, US · est. 2013

Belle Capital LP: A US-based venture capital firm investing in mobile, internet, IT, life sciences, and clean tech sectors.

Investment Firm175

Marc Bell CapitalBoca Raton, FL, USest. 2003Marc Bell CapitalBoca Raton, FL, US · est. 2003

Marc Bell Capital: A Florida-based private equity firm specializing in diverse investments, primarily in commercial and real estate sectors.

Investment Firm30

Corbel Capital PartnersLos Angeles, CA, USest. 2013Corbel Capital PartnersLos Angeles, CA, US · est. 2013

LA-based Corbel Capital Partners is a private equity firm specializing in non-control consumer and retail investments.

Investment Firm24

Colbeck Capital ManagementNew York City, NY, USest. 2009Colbeck Capital ManagementNew York City, NY, US · est. 2009

Colbeck Capital Management, LLP: A private credit manager specializing in distressed debt and strategic lending.

Investment Firm22

Leadership at Two River

David TanenCo-Founder

Similar to Two River

RiverVestSt. Louis, MO, USest. 2000RiverVestSt. Louis, MO, US · est. 2000

RiverVest Venture Partners®: A venture capital firm shaping early-stage life science companies for shareholder value.

Investment Firm36

WestRiver GroupSeattle, WA, USest. 2002WestRiver GroupSeattle, WA, US · est. 2002

WestRiver Group: A global investment firm specializing in tech, life sciences, energy, and experiential sectors.

Investment Firm123

Riveria Investment GroupNew York City, NY, USest. 2012Riveria Investment GroupNew York City, NY, US · est. 2012

Riveria Investment Group: A US-based private equity firm specializing in diverse sector investments.

Investment Firm12

RTW Venture FundNew York City, NY, USest. 2019RTW Venture FundNew York City, NY, US · est. 2019

NY-based RTW Biotech Opportunities Ltd invests in high-growth life sciences and med-tech innovations.

Investment Firm2

Leadership at Kronos Bio

Norbert BischofbergerBoard Member

Elena RidloffBoard Member

Otello StampacchiaBoard Member

Angela KoehlerCo-Founder

Marianne De BackerBoard Member

Similar to Kronos Bio

Clovis OncologyBoulder, CO, USCancer Treatmentsest. 2009Clovis OncologyBoulder, CO, US · est. 2009

Clovis Oncology, a global biotech firm, specializes in developing and commercializing cancer treatments.

Public · $145M413

Leadership at Allogene Therapeutics

Arie BelldegrunExecutive Chairman

David ChangFounder

Liz BarrettBoard Member

Stephen L. MayoBoard Member

Debbie MessemerBoard Member

Owen WitteBoard Member

Similar to Allogene Therapeutics

Senti BiosciencesSouth San Francisco, CA, USCancer Therapiesest. 2016Senti BiosciencesSouth San Francisco, CA, US · est. 2016

Senti Biosciences: Innovating cell-based, programmable cancer therapies.

Public · $215.9M122

Leadership at IconOVir Bio

Mark McCamishCEO

Clodagh O’SheaFounder

Helen S. KimBoard Member

Similar to IconOVir Bio

Unleash Immuno OncolyticsSt. Louis, MO, USOncolytic Virusest. 2015Unleash Immuno OncolyticsSt. Louis, MO, US · est. 2015

Unleash IO, a pharmaceutical firm, innovates oncolytic virus immunotherapy products targeting malignant cells.

DnatrixHouston, TX, USOncolytic Virus Therapiesest. 2005DnatrixHouston, TX, US · est. 2005

DNAtriX, a Houston-based biotech firm, develops oncolytic virus platforms to treat malignant glioma.

Series B · $57.1M33

VyriadRochester, MN, USCancer Treatmentsest. 2016VyriadRochester, MN, US · est. 2016

Omnis Pharma, Inc.: A US-based pharmaceutical company specializing in cancer treatments.

Series B · $63.4M51

Humane GenomicsNew York City, NY, USOncolytic Virus Therapiesest. 2019Humane GenomicsNew York City, NY, US · est. 2019

Engineers cancer-targeting viruses with high specificity, focusing on pediatric liver cancer.

Leadership at Kirax

Neil FlanzraichCEO

Edmundo MunizFounder

Similar to Kirax

Baudax BioMalvern, PA, USPharmaceuticalsest. 2019Baudax BioMalvern, PA, US · est. 2019

Baudax Bio: A specialty pharma company innovating acute care solutions.

Public · $116.2M20

Karyopharm TherapeuticsNewton, MA, USPharmaceuticalsest. 2008Karyopharm TherapeuticsNewton, MA, US · est. 2008

US-based Karyopharm Therapeutics offers oncology-focused pharmaceutical solutions, specializing in multiple myeloma treatments.

Public · $546.7M385

Corridor PharmaceuticalsTowson, MD, USDrugs, Pharmaceuticalsest. 2007Corridor PharmaceuticalsTowson, MD, US · est. 2007

Corridor Pharmaceuticals: A biopharmaceutical firm innovating therapeutic drugs for critical care diseases across the US.

Public · $27.6M6

AcelRx PharmaceuticalsRedwood City, CA, USPharmaceuticalsest. 2005AcelRx PharmaceuticalsRedwood City, CA, US · est. 2005

AcelRx Pharmaceuticals (rebranded as Talphera, Nasdaq: TLPH) develops innovative specialty therapies for medically supervised healthcare settings.

Leadership at Hubble Contacts

Benjamin CoganCo-Founder

Drew TarlowBoard Member

Steve DruckmanCEO

Jesse HorwitzCo-Founder

Similar to Hubble Contacts

Warby ParkerNew York City, NY, USContact Lenses, Eyewearest. 2010Warby ParkerNew York City, NY, US · est. 2010

Warby Parker: A leading American retailer of eyewear, offering prescription glasses and contact lenses.

Public · $535.5M3k

QronoPittsburgh, PA, USCancer Therapiesest. 2010

QronoPittsburgh, PA, US · est. 2010

Qrono, Inc., a Pittsburgh-based biotech company, specializes in developing cancer tumor therapies.

Angel · $50k8

Revolution MedicinesRedwood City, CA, USOncology Therapiesest. 2014Revolution MedicinesRedwood City, CA, US · est. 2014

US-based Revolution Medicines, Inc. discovers novel oncology therapies targeting elusive growth pathways globally.

Public · $1.1B246

ImageneBioBoston, MA, USCancer Therapiesest. 2016ImageneBioBoston, MA, US · est. 2016

Ikena: A targeted oncology firm developing novel therapies to combat cancer's formation and spread.

Public · $209M68

Alaunos TherapeuticsHouston, TX, USCancer Treatmentest. 2005

Alaunos TherapeuticsHouston, TX, US · est. 2005

Alaunos Therapeutics: A global clinical-stage company specializing in TCR-T cell therapy for solid tumors.

Public · $293.4M34

Atara BiotherapeuticsSouth San Francisco, CA, UST-Cell Therapiesest. 2012Atara BiotherapeuticsSouth San Francisco, CA, US · est. 2012

Atara Biotherapeutics: A clinical-stage biotech firm dedicated to developing therapies for severe diseases.

Public · $499.8M334

ImmuneBridgeSan Francisco, CA, USCancer Therapiesest. 2018ImmuneBridgeSan Francisco, CA, US · est. 2018

ImmuneBridge pioneers in developing allogeneic immunotherapies for cancer using cord blood-derived stem cells.

JetLensesAhmedabad, Gujarat, INContact Lensesest. 2018

JetLensesAhmedabad, Gujarat, IN · est. 2018

JetLenses: Affordable online contact lens provider

Seed · $120k5

Optikal CareAtlanta, GA, USContact Lenses, Eye Careest. 2016Optikal CareAtlanta, GA, US · est. 2016

Optikal delivers contact care subscription boxes to your doorstep quarterly.

EveryDay ContactsAlbuquerque, NM, USContact Lensesest. 2019EveryDay ContactsAlbuquerque, NM, US · est. 2019

Everyday Contacts: Premium daily disposable lenses promoting eye health with unique wettability technology.